Wathsala Manindrani: Managing Severe Hypertriglyceridemia in Resource-Limited Settings
Wathsala Manindrani, Transfusion Medicine Senior Registrar at National Cancer Institute, Sri Lanka, shared a post on LinkedIn:
“Managing severe hypertriglyceridaemia can be challenging, specially in resource-limited settings.
Recently, we managed a patient with familial hypertriglyceridaemia requiring urgent lipid reduction.
An automated Therapeutic Plasma Exchange (TPE) was initially attempted.
However, due to the extremely high triglyceride levels, the procedure could not be continued as the machine generated persistent alarms related to the lipemic plasma.
In Sri Lanka, Lipoprotein Apheresis (LA) using lipoadsorption columns is not currently available.
Therefore, our team proceeded with a manual plasma exchange, which allowed us to successfully remove the lipemic plasma and continue the therapeutic intervention.
This case highlights how clinical adaptability and teamwork are essential in transfusion medicine, particularly in settings where advanced apheresis technologies are limited.
Even with resource constraints, effective patient care can be achieved through thoughtful modification of available techniques.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care